Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 113.48
(-0.65%)
CNY 113.48
(-0.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 348.7 Million CNY | 29.66% |
| 2022 | 268.93 Million CNY | 38.56% |
| 2021 | 194.09 Million CNY | 37.87% |
| 2020 | 140.77 Million CNY | 31.9% |
| 2019 | 106.73 Million CNY | 40.45% |
| 2018 | 75.99 Million CNY | 43.63% |
| 2017 | 52.91 Million CNY | 5.71% |
| 2016 | 50.05 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 80.81 Million CNY | 24.91% |
| 2024 Q1 | 64.69 Million CNY | -40.73% |
| 2024 Q3 | 64.5 Million CNY | -144.33% |
| 2023 Q4 | 109.15 Million CNY | 35.4% |
| 2023 Q3 | 80.61 Million CNY | 0.16% |
| 2023 Q2 | 80.48 Million CNY | 7.82% |
| 2023 FY | 348.7 Million CNY | 29.66% |
| 2023 Q1 | 74.65 Million CNY | -28.21% |
| 2022 Q2 | 42.38 Million CNY | -33.83% |
| 2022 Q1 | 64.04 Million CNY | -6.05% |
| 2022 Q3 | 58.52 Million CNY | 38.09% |
| 2022 FY | 268.93 Million CNY | 38.56% |
| 2022 Q4 | 103.98 Million CNY | 77.67% |
| 2021 Q3 | 42.94 Million CNY | 11.35% |
| 2021 Q4 | 68.16 Million CNY | 58.73% |
| 2021 FY | 194.09 Million CNY | 37.87% |
| 2021 Q2 | 38.56 Million CNY | -13.15% |
| 2021 Q1 | 44.4 Million CNY | -20.19% |
| 2020 Q2 | 27.88 Million CNY | 89.56% |
| 2020 Q1 | 14.7 Million CNY | -62.62% |
| 2020 FY | 140.77 Million CNY | 31.9% |
| 2020 Q4 | 55.64 Million CNY | 30.78% |
| 2020 Q3 | 42.54 Million CNY | 52.59% |
| 2019 Q3 | 30.59 Million CNY | 80.53% |
| 2019 Q2 | 16.94 Million CNY | -14.62% |
| 2019 Q1 | 19.84 Million CNY | -29.83% |
| 2019 FY | 106.73 Million CNY | 40.45% |
| 2019 Q4 | 39.34 Million CNY | 28.61% |
| 2018 Q1 | -28.24 Million CNY | 0.0% |
| 2018 FY | 75.99 Million CNY | 43.63% |
| 2018 Q4 | 28.28 Million CNY | 33.85% |
| 2018 Q3 | 21.13 Million CNY | 1700.38% |
| 2018 Q2 | 1.17 Million CNY | 104.16% |
| 2017 FY | 52.91 Million CNY | 5.71% |
| 2016 FY | 50.05 Million CNY | 0.0% |